💊

Thiotepa Riemser

thiotepa

Trapianto di cellule staminali ematopoietiche;Neoplasie

✅ Autorizzato Generico

✅

Nessun allarme attivo

Questo medicinale non presenta carenze in corso, lettere di sicurezza o richiami.

A cosa serve

Thiotepa Riemser is indicated, in combination with other chemotherapy medicinal products: with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients; when high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients. Thiotepa Riemser is indicated, in combination with other chemotherapy medicinal products: with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients; when high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients

⚠️ Sicurezza del paziente

Pagina ufficiale EMA

https://www.ema.europa.eu/en/medicines/human/EPAR/thiotepa-riemser